Indegene Ltd IPO, which opened for subscription today, has already got positive response. The Rs 1,842-crore IPO is a mix of fresh issue and offer for sale by existing shareholders. The price band for the issue is Rs 430-452 per share.
On a standalone basis, in FY23, the company s revenue from operations grew 4 percent to Rs 151.16 crore, from Rs 145.47 crore in FY22, while EBITDA grew by around 76 percent to Rs 20.22 crore, from Rs 11.49 crore.
Private equity and venture capital-backed firms Indegene, a pharma player and skincare brand Mamaearth’s parent Honasa Consumer have received approval from Securities and Exchange Board ..